Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1911 2
1912 1
1913 1
1931 1
1969 1
1980 1
1997 2
2000 1
2001 2
2002 2
2003 8
2004 6
2005 10
2006 12
2007 7
2008 7
2009 7
2010 6
2011 2
2012 2
2013 1
2014 1
2015 2
2016 1
2019 2
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 16080492

83 results

Results by year

Filters applied: . Clear all
Page 1
A phase I/randomized phase II, non-comparative, multicenter, open label trial of CP-547,632 in combination with paclitaxel and carboplatin or paclitaxel and carboplatin alone as first-line treatment for advanced non-small cell lung cancer (NSCLC).
Cohen RB, Langer CJ, Simon GR, Eisenberg PD, Hainsworth JD, Madajewicz S, Cosgriff TM, Pierce K, Xu H, Liau K, Healey D. Cohen RB, et al. Cancer Chemother Pharmacol. 2007 Jun;60(1):81-9. doi: 10.1007/s00280-006-0352-0. Epub 2006 Oct 10. Cancer Chemother Pharmacol. 2007. PMID: 17031646 Clinical Trial.
Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
Pallarés C, Capdevila J, Paredes A, Farré N, Ciria JP, Membrive I, Basterrechea L, Gomez-Segura G, Barnadas A. Pallarés C, et al. Lung Cancer. 2007 Nov;58(2):238-45. doi: 10.1016/j.lungcan.2007.06.003. Epub 2007 Jul 20. Lung Cancer. 2007. PMID: 17658655 Clinical Trial.
A multicenter phase II study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer: Kyushu thoracic oncology group trial.
Ichiki M, Kawasaki M, Takayama K, Ninomiya K, Kuba M, Iwami F, Miyazaki N, Oishi K, Takeo S, Aizawa H, Nakanishi Y. Ichiki M, et al. Cancer Chemother Pharmacol. 2006 Sep;58(3):368-73. doi: 10.1007/s00280-005-0168-3. Epub 2006 Jan 4. Cancer Chemother Pharmacol. 2006. PMID: 16395589 Clinical Trial.
83 results